Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

Science(2021)10.1126/science.abe6959Source: DataRank Database

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus is a research paper published in Science (2021). On theSindex it has a DataRank of 0. It has been cited 846 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access846 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 47.32)OA: hybridTopics (40)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kyle Reinholt,Stephen M. Kissler ORCID,Marc Lipsitch ORCID,Sarah Cobey ORCID,Yonatan H. Grad ORCID

Live enrichment

PubMed:33479118 PMC:PMC7963218 OpenAlex:https://openalex.org/W3123021790

National Institutes of Health

Grant: 3U24GM132013-02S2

NIGMS NIH HHS

Grant: U24 GM132013

NCI NIH HHS

Grant: U01 CA261277

Morris-Singer Fund

Wellcome Trust

FWCI

47.32

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://www.science.org/cms/asset/0be2b882-086d-49fc-b258-347611b9e774/pap.pdf

publisherhttps://www.science.org/cms/asset/0be2b882-086d-49fc-b258-347611b9e774/pap.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1126/science.abe6959

publisherhttps://www.science.org/doi/pdf/10.1126/science.abe6959

journalhttps://doi.org/10.1126/science.abe6959

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesInfluenza Virus Research Studies

MeSH Terms

Immunogenicity, VaccineCOVID-19SARS-CoV-2COVID-19 VaccinesAdolescentAdultAge FactorsAgedAntibodies, ViralChildHealth PrioritiesHumansMiddle AgedModels, TheoreticalSeroepidemiologic StudiesMass VaccinationYoung Adult

Keywords

SerostatusPrioritizationVaccinationTransmission (telecommunications)Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicMedicinePreparednessCumulative incidenceHerd immunityImmunologyComputer scienceDiseaseCohortViral loadHuman immunodeficiency virus (HIV)BusinessPolitical scienceInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being